|
1）Kuroki Y, Toyoda A, Noguchi H, et al. Comparative analysis of chimpanzee and human Y chromosomes unveils complex evolutionary pathway. Nat Genet. 2006; 38: 158-67
|
|
|
|
2）Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med.1995; 25: 63-77
|
|
|
|
|
|
3）Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science. 2010; 330: 612-6
|
|
|
|
|
|
4）Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet. 2000; 1: 11-9
|
|
|
|
|
|
5）Wolffe AP, Pruss D. Targeting chromatin disruption: Transcription regulators that acetylate histones. Cell. 1996; 84: 817-9
|
|
|
|
|
|
6）Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet. 2011; 12: 7-18
|
|
|
|
|
|
7）Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-33
|
|
|
|
|
|
8）Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391: 806-11
|
|
|
|
|
|
9）Kanki Y, Kohro T, Jiang S, et al. Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression. EMBO J. 2011; 30: 2582-95
|
|
|
|
|
|
10）Mimura I, Nangaku M, Kanki Y, et al. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol Cell Biol. 2012; 32: 3018-32
|
|
|
|
|
|
11）Luch A. Nature and nurture - lessons from chemical carcinogenesis. Nat Rev Cancer. 2005; 5: 113-25
|
|
|
|
|
|
12）Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008; 105: 17046-9
|
|
|
|
|
|
13）Smith ZD, Chan MM, Mikkelsen TS, et al. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature. 2012; 484: 339-44
|
|
|
|
|
|
14）Kimura H. Histone modifications for human epigenome analysis. J Hum Genet. 2013; 58: 439-45
|
|
|
|
|
15）Sabin LR, Delas MJ, Hannon GJ. 2013. Dogma derailed: the many influences of RNA on the genome. Mol Cell. 2013; 49: 783-94
|
|
|
|
|
|
16）Zhao R, Bodnar MS, Spector DL. Nuclear neighborhoods and gene expression. Curr Opin Genet Dev. 2009; 19: 172-9
|
|
|
|
|
|
17）Gruenbaum Y, Margalit A, Goldman RD, et al. The nuclear lamina comes of age. Nat Rev Mol Cell Biol. 2005; 6: 21-31
|
|
|
|
|
|
18）Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-89
|
|
|
|
|
|
19）Villeneuve LM, Reddy MA, Lanting LL, et al. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A. 2008; 105: 9047-52
|
|
|
|
|
|
20）Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease? J Intern Med. 2007; 261: 488-99
|
|
|
|
|
|
21）Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 2008; 18: 131-40
|
|
|
|
|
|
22）Bechtel W, McGoohan S, Zeisberg EM, et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010; 16: 544-50
|
|
|
|
|
|
23）Sun G, Reddy MA, Yuan H, et al. Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol. 2010; 21: 2069-80
|
|
|
|
|
|
24）Chung AC, Huang XR, Meng X, et al. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol. 2010; 21: 1317-25
|
|
|
|
|
|
25）Appel LJ, Wright JT Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010; 363: 918-29
|
|
|
|
|
|
26）Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329: 841-5
|
|
|
|
|
|
27）Mu S, Shimosawa T, Ogura S, et al. Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med. 2011; 17: 573-80
|
|
|
|
|
|
28）Zhang D, Yu ZY, Cruz P, et al. Epigenetics and the control of epithelial sodium channel expression in collecting duct. Kidney Int. 2009; 75: 260-7
|
|
|
|
|
|
29）Piontek K, Menezes LF, Garcia-Gonzalez MA, et al. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med. 2007; 13: 1490-5
|
|
|
|
|
|
30）Kuwahara K, Saito Y, Takano M, et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 2003; 22: 6310-21
|
|
|
|
|